Vimarsana
Biggest News Aggregation in the World

Page 37 - Thc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thc Today - Breaking & Trending Today

Tenet Healthcare (NYSE:THC) PT Raised to $147.00 at Barclays - Vimarsana News

Tenet Healthcare (NYSE:THC) PT Raised to $147.00 at Barclays

Tenet Healthcare (NYSE:THC – Get Free Report) had its target price lifted by investment analysts at Barclays from $113.00 to $147.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Barclays‘s price objective indicates a potential upside of 22.21% from the stock’s current […]

The Cannabis Crossroads: How Schedule III and The Farm Bill Intersect - Vimarsana News

The Cannabis Crossroads: How Schedule III and The Farm Bill Intersect

The intersection of the Farm Bill and Schedule III. What it means. The future of OTC THC consumption is low-dose THC products. Hemp could be the future of adult use.

Source: forbes.com
2 charged after child hospitalized for eating THC gummy - Vimarsana News

2 charged after child hospitalized for eating THC gummy

Two people have been charged after a 4-year-old ate a THC gummy and was hospitalized as a result, according to the Boone County Sheriff's Office.

Source: lex18.com
Tenet Healthcare (NYSE:THC) Given Buy Rating at Mizuho - Vimarsana News

Tenet Healthcare (NYSE:THC) Given Buy Rating at Mizuho

Mizuho reissued their buy rating on shares of Tenet Healthcare (NYSE:THC – Free Report) in a report released on Wednesday, Benzinga reports. The brokerage currently has a $130.00 price target on the stock, up from their previous price target of $118.00. A number of other analysts also recently weighed in on THC. Stephens increased their […]

Source: wkrb13.com
Tenet Healthcare's (THC) "Buy" Rating Reaffirmed at Mizuho - Vimarsana News

Tenet Healthcare's (THC) "Buy" Rating Reaffirmed at Mizuho

Mizuho restated their buy rating on shares of Tenet Healthcare (NYSE:THC – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. Mizuho currently has a $130.00 target price on the stock, up from their prior target price of $118.00. Several other research analysts have also issued reports on the company. Wolfe […]